Page last updated: 2024-09-03

brl 44408 and Acute Lung Injury

brl 44408 has been researched along with Acute Lung Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cong, Z; Li, D; Lyu, X; Tao, Y; Zhu, X1
Fan, YX; Ji, MH; Li, GM; Li, N; Liu, FF; Tian, M; Wu, J; Yang, JJ; Zhu, XL1

Other Studies

2 other study(ies) available for brl 44408 and Acute Lung Injury

ArticleYear
[BRL-44408 maleate, the antagonist of α
    Zhonghua wei zhong bing ji jiu yi xue, 2018, Volume: 30, Issue:2

    Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Imidazoles; Isoindoles; Lipopolysaccharides; Lung; Male; Maleates; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; Receptors, Adrenergic, alpha-2; Signal Transduction; Tumor Necrosis Factor-alpha

2018
Alpha 2A-adrenoreceptor blockade improves sepsis-induced acute lung injury accompanied with depressed high mobility group box-1 levels in rats.
    Cytokine, 2012, Volume: 60, Issue:3

    Topics: Acute Lung Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Cecum; Down-Regulation; Enzyme Activation; HMGB1 Protein; Imidazoles; Interleukin-10; Interleukin-6; Isoindoles; Lung; Male; NF-kappa B; Norepinephrine; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha

2012